ELAN 13.44 (+0.98%)
US28414H1032Drug ManufacturersDrug Manufacturers - Specialty & Generic

Elanco Animal Health (ELAN) Financial Metrics

This table shows a selected set of financial data points of Elanco Animal Health (ELAN). You can choose which elements to display by selecting the desired chart and column.

MarketCap

Total Revenue

Free CashFlow

Year EPS Dividend Yield PE Ratio MarketCap Return On Assets Total Revenue Free CashFlow EBITDA Net Income Cash
2023 -2.5 0 -5.96 7.34B -0.08 4.42B 117M 945M -1.23B 352M
2022 -0.16 0 -76.52 5.97B -0 4.41B 268M 1.03B -78M 345M
2021 -0.99 0 -28.63 13.83B -0.03 4.76B 286M 1.02B -483M 638M
2020 -1.3 0 -23.59 13.54B -0.04 3.27B -352M 613M -574M 495M
2019 0.18 0 160.05 10.87B 0.01 3.07B 26.7M 543M 67.9M 334M
2018 0.28 0 114.36 9.89B 0.01 3.07B 352.8M 439.7M 86.5M 474.8M
2017 -0.87 0 0 0 -0.04 2.89B 75.2M 85.8M -310.7M 323.4M
2016 -0.13 0 0 0 -0.01 2.91B 45.6M 232M -47.9M 258.8M
2015 -0.59 0 0 0 0 2.91B -93.5M -22.6M -210.8M 0

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.